We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Cardiology

Journal Scan / Research · December 26, 2019

Cilostazol vs Aspirin in Ischemic Stroke Patients With High-Risk Cerebral Hemorrhage

Stroke: A Journal of Cerebral Circulation

 

Additional Info

Stroke: A Journal of Cerebral Circulation
Cilostazol Versus Aspirin in Ischemic Stroke Patients With High-Risk Cerebral Hemorrhage: Subgroup Analysis of the PICASSO Trial
Stroke 2019 Dec 20;[EPub Ahead of Print], BJ Kim, SU Kwon, JH Park, YJ Kim, KS Hong, LKS Wong, S Yu, YH Hwang, JS Lee, J Lee, JH Rha, SH Heo, SH Ahn, WK Seo, JM Park, JH Lee, JH Kwon, SI Sohn, JM Jung, JC Navarro, HY Kim, EG Kim, S Kim, JK Cha, MS Park, HS Nam, DW Kang

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading